v3.26.1
STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss $ (12,914,337) $ (9,663,657)
Adjustments to reconcile net loss to net cash used in operating activities    
Stock options issued for services 950,449 1,282,692
Amortization of deferred compensation 182,219 401,863
Performance stock units issued for services 384,925
Restricted stock units issued for services 2,371,949 11,113
Common stock issued for commitment shares 243,830
Depreciation and amortization of patents 987,257 943,089
Amortization of right of use asset 108,140 100,938
Accretion of interest on marketable securities (33,726)
(Gain) loss on disposal of property and equipment and intangible assets 41,679 (28,800)
(Increase) decrease in assets    
Accounts receivable 174,624 34,812
Prepaid expenses and other current assets (1,547,998) (237,115)
(Decrease) increase in liabilities    
Accounts payable (32,542) (195,411)
Accrued bonuses, accrued expenses and other liabilities (112,569) (394,875)
Accounts payable and accrued expenses-related parties (56,250) (53,359)
Contract liability 93,459 (8,333)
Operating lease liability (94,891) (81,934)
Net cash used in operating activities (9,882,537) (7,260,222)
CASH FLOWS FROM INVESTING ACTIVITIES    
Cost of intangibles (245,398) (108,332)
Purchase of property and equipment (1,518,336) (893,894)
Purchases of marketable securities (48,714,585)
Net cash used in investing activities (50,478,319) (1,002,226)
CASH FLOWS FROM FINANCING ACTIVITIES    
Exercise of options and warrants 8,309,618 204,000
Cashless option exercise tax payments (171,926)
Cashless tax payment on vested restricted stock awards (12,875)
Tax payment on net issuance of vested restricted stock units (2,088,366)
Tax payment on net issuance of performance stock units (481,103)
Issuance of common stock, institutional investor 2,174,983
Issuance of common stock to investment bank 4,930,928
Common stock sales at the market by investment banking company 27,883,977 507,248
Net cash provided by financing activities 38,555,054 2,701,430
Effect of fair value changes on cash equivalents (2,404)
NET DECREASE IN CASH AND CASH EQUIVALENTS (21,808,206) (5,561,018)
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD 69,017,354 27,667,964
CASH AND CASH EQUIVALENTS - END OF PERIOD 47,209,148 22,106,946
Supplemental Disclosure of Non-cash activities:     
   Options issued to settle accrued bonuses 48,068
   Trade-in credit for purchase of property and equipment 28,800
   Non-cash repurchase of shares issued for net option exercise 172,359
   Restricted stock awards issued for services $ 169,846